3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
11
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Non-Hodgkin
5
Lymphoma
3
Waldenstrom Macroglobulinemia
2
Neoplasms
2
Burkitt Lymphoma
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms, Castration-Resistant
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic
1
Leukemia, Myeloid, Acute
1
Leukemia, Hairy Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Anemia
1
Interventions
Carboplatin
29
pembrolizumab
25
Pemetrexed
25
Specimen Handling
22
Cisplatin
20
Magnetic Resonance Spectroscopy
18
Paclitaxel
15
Gemcitabine
13
Docetaxel
12
durvalumab
9
Nivolumab
8
osimertinib
7
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
atezolizumab
6
Etoposide
6
Platinum
5
Cetuximab
5
1,2-diaminocyclohexaneplatinum II citrate
5
X-Rays
4
Ramucirumab
4
Radiotherapy
4
Radiation
4
Observation
4
Interviews as Topic
4
Biopsy
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
ibrutinib
×
30 days
×
Clear all
No trials found.